Use App
Trending
News
Earnings
All
DIA
0.48%
SPY
0.10%
QQQ
1.12%
Trending
MLTX
1.76%
ETH
2.10%
SHIB
26.09%
LTC
3.46%
SPY
0.10%
USO
2.01%
VOO
0.08%
SLV
1.02%
QQQ
1.12%
TRUMP
0.25%
MLTX
1.76%
ETH
2.10%
SHIB
26.09%
LTC
3.46%
SPY
0.10%
USO
2.01%
VOO
0.08%
SLV
1.02%
QQQ
1.12%
TRUMP
0.25%
Feed
News
Sentiment
Fundamentals
Info
home
Symbol
NRSN
Exchange:
NASDAQ
·
Updated 07:13 PM EDT
NRSN
NeuroSense Therapeutics Ltd
$0.6021
$0.0529
(8.08%)
Today
·
Closed $0.6021
$0.0001
(0.02%)
After Hours
3
,
5
3
0
3
,
5
3
0
Mkt Cap
$21.28M
Vol
161,002.00
Full Chart
Fundamentals
Mkt Cap
$21.28M
Volume
-
52W High
$2.09
52W Low
$0.58
PE Ratio
-1.03
Avg. Volume
221,977.60
EPS (Annual)
-$0.4366
P/B
5.41
Rev/Employee
$0.00
Earnings
-
Advertisement
|
Remove ads.
Latest NRSN News
View
NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS
PR Newswire
NeuroSense to Participate in Roth-Hosted KOL Webinar on the Future of ALS Treatment: "A Quest to Outrun ALS"
PR Newswire
NeuroSense Achieves Primary Endpoint in Phase 2b ALS Study with Statistically Significant Reduction of TDP-43, the Defining Pathological Hallmark of ALS
PR Newswire
Loading...
Top Discussions
HIMS
$HIMS stock is tumbling today, reversing yesterday's rally, even after an FDA panel recommended adding several peptides to the compounding list. Are you buying the dip?
5
7
1.1K votes
SPY
What do you think the S&P 500's ($SPY) return will be next week?
44
108
14.3K votes
HIMS
The FDA is deciding whether to add peptides to the compounding list, a ruling that could be huge for $HIMS. How do you think it goes?
5
2
524 votes
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile